Skip to main content
Premium Trial:

Request an Annual Quote

RBM Collaborating with Institut Pasteur Project on Immunology Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Rules-Based Medicine said today that it will collaborate with the Institut Pasteur on a project aimed at gaining a better understanding of the human immune system.

RBM will use its TruCulture in vitro model in the project called Milieu Interieur to "establish the parameters that characterize the immune system of healthy individuals," RBM said.

The company's TruCulture system, which will be used for blood collection and culture, captures immune cell activity without many of the variables associated with sample collection and manipulation, RBM said. An important advantage of TruCulture, it added, is that cell stimulations are performed at the point of collection, providing a more accurate picture of a subject's immune response and allowing researchers to describe individual differences at the genomic, proteomic, and inflammation pathway levels.

Milieu Interieur is funded through a LabEx grant from the French government. As part of it, researchers from Institut Pasteur, the French National Institute of Health and Medical Research, and the National Centre for Scientific Research will employ technology from disciplines such as genomics, molecular biology, bioinformatics, and immunology, with the hopes that therapeutic strategies may be tailored for specific individuals, RBM said.

Terms of the deal were not disclosed.

Myriad Genetics is in the process of buying Austin, Texas-RBM for $80 million.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.